Latest Breaking News On - Alain weill - Page 12 : comparemela.com

email article Women taking the synthetic progestogen cyproterone acetate were at increased risk for brain tumors, a French study found. The analysis of data on over 250,000 girls and women who filled a prescription for cyproterone acetate showed that these individuals had a six-fold higher risk for developing an intracranial meningiomas compared with women not using the hormone (adjusted hazard ratio 6.6, 95% CI 4.0-11.1), reported Alain Weill, MD, of EPI-PHARE Scientific Interest Group in France, and colleagues in Cyproterone acetate, a synthetic progestogen with antiandrogen effects, is currently approved in most European countries but not in the U.S. Across Europe, the drug has varying indications, including for hirsutism or hyperandrogenism spectrum in women and inoperable prostate cancer and paraphilias in men. In addition, given the antiandrogen properties, cyproterone acetate is also used as feminizing hormone therapy for transgender women.

New yorkUnited statesAlain weillScientific interest groupInterest groupNew york cityMass lesion of brainNeoplasm of brainNeoplastic diseaseபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்அலன் வெயில்அறிவியல் ஆர்வம் குழுஆர்வம் குழுபுதியது யார்க் நகரம்